Atlas Trials

Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity

Clinical trial NCT07778693 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07778693
Sponsor
Shanghai Minwei Biotechnology Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Overweight , Obesity
Start date
2026-09-01
Primary completion
2027-09-01
Enrollment
760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.